SEC Comment Letter for Black Bird Biotech, Inc. (BBBT) (CIK 0001409999) — May 11, 2020
Black Bird Biotech, Inc. (BBBT) (CIK 0001409999)
Date: May 11, 2020 · CIK: 0001409999 · Accession: 0000000000-20-004130
AI Filing Summary & Sentiment
Show Raw Text
United States securities and exchange commission logo
May 11, 2020
Fabian G. Deneault
Chairman and President
Digital Development Partners, Inc.
17800 Castleton Street, Suite 300
City of Industry, CA 91748
Re:Digital Development Partners, Inc.
Amendment 1 to Current Report on Form 8-K
Filed April 3, 2020
File No. 0-52828
Dear Mr. Deneault:
We issued comments to you on the above captioned filing on April 14, 2020. As of the
date of this letter, these comments remain outstanding and unresolved. We expect you to
provide a complete, substantive response to these comments within 10 business days from the
date of this letter.
If you do not respond, we will, consistent with our obligations under the federal securities
laws, decide how we will seek to resolve material outstanding comments and complete our
review of your filing and your disclosure. Among other things, we may decide to release
publicly, through the agency's EDGAR system, all correspondence, including this letter, relating
to the review of your filings, consistent with the staff's decision to publicly release comment and
response letters relating to disclosure filings it has reviewed.
Please contact Edward M. Kelly, Senior Counsel, at (202) 551-3728, Melissa Gilmore,
Staff Accountant, at (202) 551-3777, or Claire Erlanger, Staff Accountant, at (202) 551-
3301 with any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc: Eric J. Newlan